POWER TO THE PATIENTS
HIP HOP PSA: “We need real prices and transparency in healthcare.”
Vioxx
In August 2013, a federal judge preliminarily approved a $23 million settlement to a class-action lawsuit filed against Merck Sharp & Dohme Corp. for allegedly falsely advertising that Vioxx had greater benefits than the generic versions when these benefits had not been established. According to the settlement terms, class members may receive a cash award of up to $75 with proof of purchase. (In re: Vioxx Products Liability Litigation, MDL No. 1657, E. D. LA.).
The Latest
T-Mobile Home Internet
Bundle bungled.
Trial Court Rules Neora Is Not a Pyramid Scheme
But the majority of brand partners will still lose money.
Angel Publishing
Investment newsletter publisher needs to clip its wings.
CATrends: Where’s the Beef?
Lawsuits challenge the amount of meat and toppings depicted in fast-food marketing images.